Top 10 Companies in the Tenofovir Alafenamide Fumarate API Market (2025): Key Suppliers Powering Global HIV Treatment

In Business Insights
November 01, 2025


The Global Tenofovir Alafenamide Fumarate API Market was valued at USD 285.6 Million in 2024 and is projected to reach USD 415.3 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2024–2030). This growth is being driven by the global scale-up of HIV treatment programs, increasing adoption of TAF-based regimens, and the expanding generics market following patent expirations.

The pharmaceutical industry is undergoing a transformative period with expanding antiretroviral therapies and generics manufacturing. In this blog, we profile the Top 10 Companies in the Tenofovir Alafenamide Fumarate API Industry—a mix of innovators and generic manufacturers ensuring global access to this critical HIV medication.


🔟 1. Hetero Drugs

Headquarters: Hyderabad, India
Key Offering: Tenofovir Alafenamide Fumarate API, Antiretroviral APIs

Hetero Drugs is one of the world’s leading producers of Tenofovir Alafenamide Fumarate API, supplying both regulated and emerging markets. The company has established itself as a key supplier for global HIV treatment programs and generic pharmaceutical companies.

Quality and Regulatory Initiatives:

  • WHO prequalification for TAF API

  • Strategic partnerships with global health organizations

  • Compliance with stringent FDA and EMA standards

Download FREE Sample Report: Tenofovir Alafenamide Fumarate API Market – View in Detailed Research Report


9️⃣ 2. Mylan Laboratories (now part of Viatris)

Headquarters: Canonsburg, Pennsylvania, USA
Key Offering: TAF API, Finished Dosage Forms

Mylan, now operating as Viatris, has been a pioneer in making TAF-based regimens accessible globally through its generic versions and partnership programs.

Quality and Regulatory Initiatives:

  • First to launch generic TAF-based products in the US

  • Supports global HIV treatment scale-up through the Medicines Patent Pool


8️⃣ 3. Aurobindo Pharma Limited

Headquarters: Hyderabad, India
Key Offering: Tenofovir Alafenamide Fumarate API, ARV formulations

Aurobindo Pharma has emerged as a significant global supplier of TAF API, leveraging its extensive manufacturing capabilities and regulatory expertise across multiple markets.

Quality and Regulatory Initiatives:

  • FDA-approved manufacturing facilities

  • Expanding TAF API capacity to meet growing demand


7️⃣ 4. Laurus Labs

Headquarters: Visakhapatnam, India
Key Offering: High-purity TAF API, Custom synthesis

Laurus Labs specializes in the development and manufacturing of active pharmaceutical ingredients, with TAF API being a key focus area in their antiretroviral portfolio.

Quality and Regulatory Initiatives:

  • Strong focus on R&D for process optimization

  • Partnerships with innovator companies for authorized generics


6️⃣ 5. Emcure Pharmaceuticals

Headquarters: Pune, India
Key Offering: Tenofovir Alafenamide Fumarate API

Emcure Pharmaceuticals has developed robust manufacturing processes for TAF API and supplies to multiple regulated markets worldwide.

Quality and Regulatory Initiatives:

  • WHO-prequalified manufacturing facilities

  • Expanding API production to support global public health initiatives

Download FREE Sample Report: Tenofovir Alafenamide Fumarate API Market – View in Detailed Research Report


5️⃣ 6. Shanghai Desano Chemical Pharmaceutical

Headquarters: Shanghai, China
Key Offering: Tenofovir Alafenamide Fumarate API, Custom synthesis

Shanghai Desano is a prominent Chinese manufacturer of TAF API, supplying both domestic and international pharmaceutical markets.

Quality and Regulatory Initiatives:

  • Strategic focus on HIV treatment APIs

  • Increasing exports to Southeast Asian and African markets


4️⃣ 7. Aurisco Pharmaceutical Co., Ltd

Headquarters: Chongqing, China
Key Offering: High-purity TAF API, Pharmaceutical intermediates

Aurisco Pharmaceutical has established itself as a reliable supplier of TAF API with growing market presence in both regulated and semi-regulated markets.

Quality and Regulatory Initiatives:

  • EDQM certification for API manufacturing

  • Investment in green chemistry and sustainable manufacturing processes


3️⃣ 8. Micro Labs Limited

Headquarters: Bangalore, India
Key Offering: TAF API, Finished formulations

Micro Labs has developed comprehensive capabilities for TAF API manufacturing and supplies to multiple global markets through its regulatory-compliant facilities.

Quality and Regulatory Initiatives:

  • Strong regulatory filing capabilities across multiple regions

  • Focus on cost-effective manufacturing to improve accessibility


2️⃣ 9. Mangalam Drugs & Organics Ltd

Headquarters: Mumbai, India
Key Offering: Tenofovir Alafenamide Fumarate API

Mangalam Drugs & Organics has emerged as a significant player in the TAF API market, particularly serving the growing generic pharmaceutical industry.

Quality and Regulatory Initiatives:

  • Developing robust supply chain for TAF API raw materials

  • ISO 9001:2015 certified manufacturing facilities


1️⃣ 10. Shilpa Medicare Limited

Headquarters: Hyderabad, India
Key Offering: TAF API, Custom manufacturing

Shilpa Medicare has established itself as a reliable supplier of TAF API with growing presence in Asian and African markets.

Quality and Regulatory Initiatives:

  • FDA-approved manufacturing plants

  • Strategic focus on complex generics and specialty APIs

Get Full Report Here: Tenofovir Alafenamide Fumarate API Market – View in Detailed Research Report


🌍 Outlook: The Future of Tenofovir Alafenamide Fumarate API Is Driven by Accessibility and Innovation

The Tenofovir Alafenamide Fumarate API market is experiencing significant transformation as patent expirations open opportunities for generic manufacturers to improve global access to HIV treatment.

📈 Key Trends Shaping the Market:

  • Rising adoption of TAF-based regimens over TDF due to improved safety profile

  • Increasing focus on cost-effective manufacturing processes to support low- and middle-income countries

  • Partnerships between innovator companies and generic manufacturers through voluntary licensing

  • Strategic API capacity expansion in India and China to meet growing global demand

Get Full Report Here: Tenofovir Alafenamide Fumarate API Market – View in Detailed Research Report

The companies listed above are not only supplying critical HIV medication—they’re driving global health equity through sustainable manufacturing and strategic partnerships.